Skip to main content
. 2022 Jan 7;36(2):e24228. doi: 10.1002/jcla.24228

FIGURE 4.

FIGURE 4

The expression of ITGA5 for the prediction of recurrence‐free survival (RFS) in patients with laryngeal squamous cell carcinoma (LSCC). (A) Survival curves of RFS from the Cancer Genome Atlas (TCGA) cohort (n = 111); (B) Survival curves of RFS from the GSE27020 cohort (n = 109); (C) Survival curves of RFS from the GSE65858 cohort (n = 48); The univariate (D) and multivariate Cox regression analyses (E) of RFS according to the expression of ITGA5 after adjusting the clinical characteristics in the TCGA cohort